NCT01584713

Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC)

A Phase II Clinical Trial to Study the Feasibility and Safety of Stromal Vascular Derived From Adipose Tissue for the Treatment of Enterocutaneous Fistula

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Instituto de Investigación Hospital Universitario La Paz · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine safety of Stromal Vascular Fraction (SVF) for the treatment of enterocutaneous fistula.

Detailed description

SF-12 Test

Conditions

• Enterocutaneous Fistula

Interventions

Type	Name	Description
DRUG	Adipose-derived stem cells without expanded	Administration will be intralesional injection of cells suspension. They will be placed into fistula walls

Timeline

• Start date: 2011-12-01
• Primary completion: 2012-07-01
• Completion: 2013-12-01
• First posted: 2012-04-25
• Last updated: 2012-04-25

Locations

1 site across 1 country: Spain